Jennifer H. Lin
Jennifer H. Lin has extensive experience in cancer epidemiology and genetic epidemiology. She was trained as an experimental psychologist specializing in cognition, aging, and psychometrics. During her postdoctoral work at Washington University in St. Louis, She has been involved in the research of genomewide scans on disease outcomes including cancers as well as on surrogate markers for metabolic disorders, association analysis of the functional determinants in many hormone-associated genes, and interaction between lipoprotein genes and fasting insulin levels. Since joining Harvard Medical School and Brigham and Women’s Hospital, she has also studied the epidemiology of breast and colorectal cancers and CVD by evaluating the predictive roles of nutrients, reproductive, and hormonal factors, obesity, and metabolic disorders in disease development. As principal investigator and coinvestigator on several NIH-funded grants, she has evaluated lifestyle and hormonal factors and circulating levels and intakes of nutrients in cancer and CVD prevention as well as investigating candidate genes in cancer development, for which she has generated several peer-reviewed publications. Moreover, she has been involved in several randomized clinical trials (Women’s Antioxidant Cardiovascular Study, Women’s Health Study, and VITamin D and OmegA-3 fatty acid triaL) to evaluate the compliance, safety, and the efficacy of study agents (Vitamins A, C, ,D, E, beta carotene, aspirin, and omega-3) for primary or secondary cancer prevention as well as posttrial investigation. She is also currently working on several molecular projects evaluating epigenetic changes of tumor biomarkers in archived tumor tissue samples. Finally, she has been involved in numerous editorial activities by helping review of grant proposals and manuscripts as well as writing reviews and editorials for clinical and epidemiologic journals.
Biography Updated on 15 March 2012